Treatment adherence in individuals with rapid cycling bipolar disorder: Results from a clinical-trial setting [12]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 4, 2007, Pages 412-414

  Sajatovic, Martha ^a   Elhaj, Omar ^a,b   Youngstrom, Eric A ^a   Bilali, Sarah R ^a,c   Rapport, Daniel J ^d   Ganocy, Stephen J ^a,c   Calabrese, Joseph R ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM; VALPROIC ACID;

ADULT; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EDUCATIONAL STATUS; EMPLOYMENT; ETHNIC DIFFERENCE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RAPID CYCLING BIPOLAR DISORDER; SEX DIFFERENCE; SUBSTANCE ABUSE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; TRIAZINES; VALPROIC ACID;

EID: 34447509471     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000280310.50871.ff     Document Type: Letter

References (12)

1. Colom F, Vieta E. Treatment adherence in bipolar patients. Clin Approaches Bipolar Disord. 2002;1:49-56.
2. Muller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord. 1992;25:261-269.
3. Kupka RW, Luckenbaugh DA, Post RM, et al. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry. 2003;64(12):1483-1494.
4. Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
5. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435.
6. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766-771.
7. Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73(3):159-171.
8. Ware JE Jr, Snow KK, Kosinski M, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
9. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000;61(11):841-850.
10. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month, double-blind, maintenance trial of lithium vs. divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. 2005;162(11):2152-2561.
11. Levy JM, Remick RA. Clinical aspects and treatment of rapid cycling mood disorders. Can J Psychiatry. 1986;31(5):436-431.
12. Riedel M, Strassnig M, Muller N, et al. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials? Eur Arch Psychiatry Clin Neurosci. 2004. Published online.